Tianyi Medical (SHE: 301097), a Ningbo-based developer of Class III medical consumables, has announced plans to acquire the CRRT-filter business assets of Italy-based Bellco S.R.L., a leader in blood purification treatments, for EUR11.99 million (USD12.59 million).
Acquisition Details
The acquisition is set to position Tianyi Medical as the third company globally with a full-line of CRRT products, following Fresenius and Vantive, which was formerly the Baxter Kidney Care segment. The deal is expected to significantly enhance Tianyi Medical’s product offerings in the blood purification market.
Company Background
Tianyi Medical specializes in the development of Class III medical consumables, focusing on innovative solutions for critical care and dialysis. Bellco S.R.L., established in Italy, is renowned for its advanced blood purification treatment technologies. The acquisition is anticipated to bring synergistic benefits, combining Tianyi Medical’s manufacturing capabilities with Bellco’s technological expertise.-Fineline Info & Tech
